Post-Marketing Clinical Study of High-Pressure Cutting Balloon
NCT: NCT07835178 · RECRUITING
Brief Summary
This study is designed as a prospective, multicenter, 1:1 randomized controlled trial. It plans to enroll 280 patients with moderate-to-severe calcified coronary lesions who are candidates for IVUS-guided DES implantation. Subjects will be randomized in a 1:1 ratio to the experimental group (n=140) or the control group (n=140). The primary endpoint is the MSA measured by IVUS immediately after the procedure, with the purpose of verifying the safety and efficacy of the high-pressure cutting balloon in optimizing stent implantation outcomes.
Frequently Asked Questions
What is Post-Marketing Clinical Study of High-Pressure Cutting Balloon?
Post-Marketing Clinical Study of High-Pressure Cutting Balloon is a clinical trial registered under NCT07835178. Current status: RECRUITING.
What is the status of NCT07835178?
The current status of NCT07835178 (Post-Marketing Clinical Study of High-Pressure Cutting Balloon) is: RECRUITING.
When did Post-Marketing Clinical Study of High-Pressure Cutting Balloon start?
Post-Marketing Clinical Study of High-Pressure Cutting Balloon started on 2026-09.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.